Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia
Sponsor: LENZ Therapeutics, Inc
Summary
Phase 3 Efficacy Study to evaluate the Safety and Efficacy of LNZ100 \& LNZ101 for the Treatment of Presbyopia
Official title: A Multi-Center, Double-Masked Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia
Key Details
Gender
All
Age Range
45 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
229
Start Date
2023-03-06
Completion Date
2024-01-24
Last Updated
2026-10-08
Healthy Volunteers
Yes
Interventions
Aceclidine+Brimonidine combination ophthalmic solution
Aceclidine + Brimonidine combination ophthalmic solution
Aceclidine ophthalmic solution
Aceclidine ophthalmic solution
Vehicle
Proprietary vehicle ophthalmic solution
Locations (17)
Site #209
Dothan, Alabama, United States
Site #216
Scottsdale, Arizona, United States
Site #220
Glendale, California, United States
Site #214
La Jolla, California, United States
Site #203
Newport Beach, California, United States
Site #204
Danbury, Connecticut, United States
Site #205
Crystal River, Florida, United States
Site #218
Northbrook, Illinois, United States
Site #211
Louisville, Kentucky, United States
Site #208
St Louis, Missouri, United States
Site #215
Bozeman, Montana, United States
Site #219
Dover, New Jersey, United States
Site #221
Rochester, New York, United States
Site #212
West Fargo, North Dakota, United States
Site #207
Powell, Ohio, United States
Site #213
Eugene, Oregon, United States
Site #217
Warwick, Rhode Island, United States